Benjamin Cravatt

KYNB

Benjamin Cravatt serves as Director at Kyntra Bio, Inc. (KYNB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$67.7K

Net Position

Net Seller

$67.7K

Companies Traded

KYNB

Active Period

Jun 2023

1 total trades

Most Recent

Sell KYNB

Jun 9, 2023 · $67.7K

Benjamin Cravatt's Insider Trading at Kyntra Bio, Inc. (KYNB)

Buys

0 · $0.00

Sells

1 · $67.7K

Total Shares Bought

Total Shares Sold

3,944

KYNB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 9, 2023↗	Sell	3,944	$17.17	$67.7K	30,914

Related Insiders

David DeLucia

Chief Financial Officer

KYNBSell · Dec 6, 2025

Thane Wettig

CEO

KYNBSell · Dec 6, 2025

James A Schoeneck

Director

KYNBBuy · Jun 30, 2025

Explore More Insider Trading Data

KYNB Insider Trading Activity

View all insider trades at Kyntra Bio, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity